Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin κ/λ ratios

Clinical Chemistry

Volumn 55, Issue 9, 2009, Pages 1646-1655

  Bradwell, Arthur R ^a,b   Harding, Stephen J ^b   Fourrier, Nicolas J ^b   Wallis, Gregg L F ^b   Drayson, Mark T ^a   Carr Smith, Hugh D ^b   Mead, Graham P ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Binding Site Group Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN A KAPPA; IMMUNOGLOBULIN A LAMBDA; IMMUNOGLOBULIN G KAPPA; IMMUNOGLOBULIN G LAMBDA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M KAPPA; IMMUNOGLOBULIN M LAMBDA; TRANSFERRIN; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; AUTOMATION; CLONAL VARIATION; CONTROLLED STUDY; DEVICE; DILUTION; ELECTROPHORESIS; GEL ELECTROPHORESIS; HUMAN; IMMUNIZATION; IMMUNOASSAY; IMMUNOFIXATION ELECTROPHORESIS; IMMUNOLOGICAL TOLERANCE; MEASUREMENT; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NEPHELOMETRY; NONHUMAN; PROTEIN ELECTROPHORESIS; SENSITIVITY AND SPECIFICITY; SHEEP;

ANIMALS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; ISOELECTRIC FOCUSING; MULTIPLE MYELOMA; NEPHELOMETRY AND TURBIDIMETRY; PARAPROTEINEMIAS; SENSITIVITY AND SPECIFICITY; SHEEP; SOLID PHASE EXTRACTION;

OVIS ARIES;

EID: 69549101860     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.123828     Document Type: Article

References (20)

1. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R. Highly sensitive automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-680 (Pubitemid 32275810)
2. Bakshi NA, Guilbranson R, Garstka D, Bradwell AR, Keren DF. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis (CZE) in detecting subtle FLC M-proteins. Am J Clin Path 2005;124:214-218 (Pubitemid 41060131)
3. Hill PG, Forsyth JM, Rai B, Mayne S. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 2006;52:1743-1748 (Pubitemid 44330709)
4. Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, et al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc 2006;81:1575-1578 (Pubitemid 44871901)
5. Kyrtsonis M-C, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadgiannis A, et al. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Br J Haematol 2007;137:240-243 (Pubitemid 46537637)
6. Snozek CLH, Katzmann JA, Kyle RA, Dispenzieri A, Larson DR, Clark RJ, et al. Prognostic value of the serum free light chain ratio in patients with newly diagnosed myeloma: proposed incorporation into the International Staging System. Leukemia 2008;22:1933-1937
7. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ III, Bradwell AR Clark RJ, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005;106:812-817
8. Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, Hawkins PN. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003;122:78-84. (Pubitemid 36819341)
9. Dispenzieri A, Lacy MQ, Katzmann JA, Rajkumar SV, Abraham RS, Hayman SR, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2006;107:3378-3383
10. Pratt G, Harding S, Holder R, Fegan C, Pepper C, Oscier D, et al. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. Br J Haem 2009;144:217-222
11. Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-224
12. Kyle RA. Sequence of testing for monoclonal gammopathies: serum and urine assays. Arch Pathol Lab Med 1999;123:114-118
13. Alexanian R. Blood volume in monoclonal gammopathy. Blood 1977;49:301-307
14. Kim J, Hayton W, Robinson J, Anderson C. Kinetics of FcRn-mediated recycling of IgG and albumin in humans: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol 2007;122:146-155 (Pubitemid 46073892)
15. Akilesh S, Christianson G, Roopenian D, Shaw A. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 2007;179:4580-4588
16. Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006;68:103-114
17. Durie B, Jacobson J, Barlogie B, Crowley J. Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials. J Clin Oncol 2004;22:1857-1863 (Pubitemid 41095176)
18. Schauer U, Stemberg F, Rieger CHL, Borte M, Schubert S, Riedel F, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with The Binding Site reagents. Clin Chem 2003;49:1924-1929 (Pubitemid 37340328)
19. NCCLS. Interference testing in clinical chemistry; proposed guideline. NCCLS Publication EP7-P. Villanova (PA): NCCLS; 1986.
20. Martin W, Abraham R, Tait S, Clark RJ, Bone N, Geyer SM, et al. Serum-free light chain: a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Translat Res 2007;149:231-235 (Pubitemid 46442009)